| Literature DB >> 23921535 |
Cécile Rouzier1, Annabelle Chaussenot2, Valérie Serre3, Konstantina Fragaki1, Sylvie Bannwarth1, Samira Ait-El-Mkadem1, Shahram Attarian4, Elsa Kaphan4, Aline Cano5, Emilien Delmont6, Sabrina Sacconi6, Bénédicte Mousson de Camaret7, Marlène Rio8, Anne-Sophie Lebre8, Claude Jardel9, Romain Deschamps10, Christian Richelme11, Jean Pouget4, Brigitte Chabrol5, Véronique Paquis-Flucklinger1.
Abstract
Polymerase gamma (POLG) is the gene most commonly involved in mitochondrial disorders with mitochondrial DNA instability and causes a wide range of diseases with recessive or dominant transmission. More than 170 mutations have been reported. Most of them are missense mutations, although nonsense mutations, splice-site mutations, small deletions and insertions have also been identified. However, to date, only one large-scale rearrangement has been described in a child with Alpers syndrome. Below, we report a large cohort of 160 patients with clinical, molecular and/or biochemical presentation suggestive of POLG deficiency. Using sequencing, we identified POLG variants in 22 patients (18 kindreds) including five novel pathogenic mutations. Two patients with novel mutations had unusual clinical presentation: the first exhibited an isolated ataxic neuropathy and the second was a child who presented with endocrine signs. We completed the sequencing step by quantitative multiplex PCR of short fluorescent fragments (QMPSF) analysis in 37 patients with either only one POLG heterozygous variant or a family history suggesting a dominant transmission. We identified a large intragenic deletion encompassing part of intron 21 and exon 22 of POLG in a child with refractory epilepsia partialis continua. In conclusion, we describe the first large French cohort of patients with POLG mutations, expanding the wide clinical and molecular spectrum observed in POLG disease. We confirm that large deletions in the POLG gene are rare events and we highlight the importance of QMPSF in patients with a single heterozygous POLG mutation, particularly in severe infantile phenotypes.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23921535 PMCID: PMC3953900 DOI: 10.1038/ejhg.2013.171
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246